SS
CLPT icon

SBI Securities’s ClearPoint Neuro CLPT Stock Holding History

SBI Securities’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.59K Sell
285
-38
-12% -$480 ﹤0.01% 2325
2025
Q4 		$4.42K Sell
323
-74
-19% -$1.37K ﹤0.01% 2072
2025
Q3 		$8.65K Buy
397
+22
+6% +$259 ﹤0.01% 1831
2025
Q2 		$4.48K Buy
375
+344
+1,110% +$4.33K ﹤0.01% 2037
2025
Q1 		$369 Buy
31
+23
+288% +$358 ﹤0.01% 2992
2024
Q4 		$123 Buy
+8
New +$104 ﹤0.01% 3396

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

SBI Securities's CLPT Position: Q1 2026 in Review

SBI Securities reduced its ClearPoint Neuro (CLPT) stake by 12% in Q1 2026, selling an estimated $480 and leaving 285 shares worth $2.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2325.

SBI Securities first reported a position in CLPT in Q4 2024 and has held it in 6 quarters since. The position peaked at $8.65K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • SBI Securities held 285 shares of ClearPoint Neuro worth $2.59K as of Q1 2026.
  • SBI Securities sold 38 ClearPoint Neuro shares in Q1 2026, an estimated $480.
  • ClearPoint Neuro made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2325 holding.
  • SBI Securities first reported a position in ClearPoint Neuro in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's ClearPoint Neuro position peaked at $8.65K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.